Agglomeration of mesoporous silica by melt and steam granulation. part II: screening of steam granulation process variables using a factorial design.
The objectives of this study were to identify the key process parameters during steam granulation of disordered mesoporous silica material Syloid® 244 FP (244) and to compare two different binders: polyvinylpyrrolidone (PVP) K25 and hydroxypropylmethyl cellulose (HPMC). Itraconazole (ITZ) was selected as the model compound for the development of an oral dosage form for enhanced release. Six factors: binder content, steam amount, mixing time, impeller speed, spray pause time, and filler content were investigated using a two-level quarter-fraction factorial design of experiment (DOE) for each binder type. As experimental responses, characteristics correlating to both granules and tablets were selected. Granules prepared from PVP resulted in an overall higher bulk density, granule size, increased flow properties, and better compression and compaction behavior. Although granulation with PVP resulted in the most ITZ to extract from the pores during processing, the premature drug release was less than 5%. The results of the DOE indicate that the risk of extracting the drug from the pores during processing is governed both by the process parameters and the binder properties. Centerpoint replicates of granules prepared with HPMC were highly variable.
Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.
Monica
M
Vialpando
Beatrice
B
Albertini
Nadia
N
Passerini
Yvan
Y
Vander Heyden
Patrick
P
Rombaut
Johan A
JA
Martens
Guy
G
Van Den Mooter
D000935:Antifungal Agents / Q000008:administration & dosage; D004339:Drug Compounding / Q000379:methods*; D005079:Excipients / Q000737:chemistry*; D065347:Hypromellose Derivatives; D017964:Itraconazole / Q000008:administration & dosage; D008747:Methylcellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D011205:Povidone / Q000737:chemistry*; D012822:Silicon Dioxide / Q000737:chemistry*; D013607:Tablets
D000935:Antifungal Agents; D005079:Excipients; D013607:Tablets; D017964:Itraconazole; D065347:Hypromellose Derivatives; D012822:Silicon Dioxide; D008747:Methylcellulose; D011205:Povidone
compaction; compression; factorial design; formulation; physical stability; polyvinylpyrrolidone; poorly water-soluble drugs; powder technology; solid dosage form